Valsartan in Combination with Tripterygium Glycosides Protects against Chronic Nephritis via the Toll-Like Receptor 4 Pathway

Table 7

Incidence of adverse reactions during treatment in both groups.

Groups	Nausea and vomiting ( (%))	Dizziness and headache ( (%))	Skin rash ( (%))	Elevated transaminases ( (%))	Total incidence ( (%))
Control group ()	2 (3.64%)	2 (3.64%)	1 (1.82%)	1 (1.82%)	6 (10.91%)
Observation group ()	2 (3.64%)	1 (1.82%)	0 (0.00%)	1 (1.82%)	4 (7.27%)
	0.808